1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow B-cell Lymphoma: new trials by email Literature Review of B-cell Lymphoma trials Research Report on B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma Bevacizumab, Rituximab, CHOP - B-cell Lymphoma | Phase 3 | Terminated | Hoffmann-La Roche | 787 | 2007-07-26 | 2017-07-25 |
Lymphoma, B-Cell (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Bevacizumab (1) · Rituximab (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · China (1) · Colombia (1) · Czechia (1) · Ecuador (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Hungary (1) · Italy (1)